CrushSCI.com
79.8Average days
81Median days
66Fastest days
91Longest days
2082025 publications

Paper Review Records

All Paper Review Records

5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

91 days

Treatment attrition and outcomes of myeloma patients in Finland: a real-world study

Authors
Mervi Putkonen; Katja Närhi; Johanna Vikkula; Riikka Mattila; Marika Waltari; Jonna Eeva; Anu PartanenShow moreShow less
Affiliations
1. Hematology and Stem Cell Transplant Unit, Wellbeing Services County of Southwest Finland, Turku University Hospital, Turku, Finland; 2. Johnson & Johnson, Espoo, Finland; 3. Medaffcon Oy, Espoo, Finland; 4. Department of Medicine, Wellbeing Services County of Pirkanmaa, Tampere University Hospital, Tampere, Finland; 5. Department of Medicine, Wellbeing Services County of North Savo, Kuopio University Hospital, Kuopio, FinlandShow moreShow less
Official full-text evidence DOI Publisher page
81 days

Co-mutation patterns and survival associations in lung cancer: a comparative analysis of Swedish and global cohorts

Authors
Nicholas Karlowatz; Linda Köhn; Cedric Patthey; Jonas Nilsson; Mikael JohanssonShow moreShow less
Affiliations
1. Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden; 2. Department of Medical Biosciences, Pathology, Umeå University, Umeå, SwedenShow moreShow less
Official full-text evidence DOI Publisher page
77 days

FIN-EGFR: real-world treatment outcomes by EGFR mutational subtypes in NSCLC in Southern Finland

Authors
Aija Knuuttila; Monica H. Ekblom; Lalli O. Nurmi; Anna Bonin; Eija K. Heikkilä; Maria SilvoniemiShow moreShow less
Affiliations
1. Department of Pulmonary Medicine, Heart and Lung Center, and Cancer Center, Helsinki University Central Hospital, Helsinki, Finland; 2. Johnson & Johnson, Espoo, Finland; 3. Nordic Healthcare Group, Espoo, Finland; 4. Johnson & Johnson, Solna, Sweden; 5. Department of Respiratory Medicine, Turku University Central Hospital, Turku, FinlandShow moreShow less
Official full-text evidence DOI Publisher page
84 days

Disparities in initiating standard first-line cancer treatment and survival for patients with an immigrant background: a Danish register-based cohort study

Authors
Emma N. Ishøy; Maria Kristiansen; Ismail Gögenur; Erik Jakobsen; Lars Lund; Fie Stegenborg; Susanne Rosthøj; Mia K. Grand; Pernille Bidstrup; Morten Sodemann; Susanne O. DaltonShow moreShow less
Affiliations
1. Cancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; 2. Danish Research Center for Equality in Cancer, Zealand University Hospital, Næstved, Denmark; 3. Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 4. Center for Surgical Science, Department of Surgery, Zealand University Hospital, Køge, Denmark; 5. Department of Cardiac, Thoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark; 6. Department of Urology, Odense University Hospital, Odense, Denmark; 7. Statistics and Data Analysis, Danish Cancer Institute, Copenhagen, Denmark; 8. Psychological Aspects of Cancer, Cancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; 9. Department of Infectious Diseases, Odense University Hospital, Odense, Denmark; 10. Institute of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, DenmarkShow moreShow less
Official full-text evidence DOI Publisher page
66 days

Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature

Authors
Panagiotis Filis; Magnus Lindskog; Philip Curman; Natalia Kuzmina; Åsa Krantz; Katerina Chatzidionysiou; Fernanda Costa Svedman; Ioannis ZerdesShow moreShow less
Affiliations
1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; 2. Department of Pelvic Cancer, Genitourinary Oncology, Karolinska University Hospital, Stockholm, Sweden; 3. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; 4. Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden; 5. Dermatology and Venereology Section, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 6. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 7. Department of Rheumatology, Theme Inflammation and Geriatrics, Karolinska University Hospital, Stockholm, Sweden; 8. Rheumatology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; 9. Theme Cancer, Karolinska University Hospital, Stockholm, SwedenShow moreShow less
Official full-text evidence DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.